Lectrona logo Boehringer Ingelheim

Funding Opportunities for
Medical Education Grants

Boehringer Ingelheim is proud to provide grants for educational activities for healthcare professionals and the scientific community in order to benefit the public and improve patient health.

There are 3 types of funding opportunities available for medical education.

Independent Medical Education (IME) Grants

  • Independent, accredited or non-accredited, non-promotional and non-product specific medical education activities
  • Intended to educate HCPs, the scientific community, and may include patient education components
More information

Scientific Advancement Grants (SAG)

  • Grant funding to advance the knowledge and understanding of science (pre-clinical, outcomes or clinical) patient care and/or development of scientific/education methodologies, techniques and information
  • Allows Boehringer Ingelheim involvement in creation of materials or activities
More information

Quality Improvement Education (QIE) Grants

  • Grant funding to examine educational methodologies/tools addressing clinical performance measures or quality indicators aligned to National Quality Priorities
  • Results disseminated via publications or real-world data
  • Boehringer Ingelheim may partner with professional or medical association or society
More information

During the COVID-19 outbreak, patient, community and health care provider safety and wellbeing remains the highest priority for Boehringer Ingelheim Pharmaceuticals, Inc. ("BIPI").

The COVID-19 situation is changing on a daily basis across the world, which results in operational challenges; timelines and program-format modifications (i.e. live to virtual). It is our intent to be as flexible as reasonably possible with timelines as they pertain to start and end dates, program format, reports and other affected obligations, as stated in the agreement.

If a change of scope (COS) request is needed for an approved grant, please reach out to your BIPI Medical Education Personnel (MEP) to initiate the request within our Global Funding System.

For all payment, reconciliation, spend reporting questions or concerns; please reach out to our service mailbox at MEDSCICOMMOps.US@boehringer-ingelheim.com.

BIPI will evaluate every grant impacted on a case-by-case basis.

It is highly encouraged that any new grant submissions with a start date prior to September 1, 2020, only include virtual or print components.

Any grants after the start date of September 1, 2020, can include live activities.

We wish you, your staff and your family good health.